Clinical Trial Update: Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) [NA]

View source ↗

Summary

This entry notes an ongoing clinical trial evaluating FLT-PET imaging to monitor treatment response in neuroblastoma. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Neuroblastoma | NA | Status: UNKNOWN